PTC Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-06-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-05-29; Total offering amount $41,905,000.
- 2020-05-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-04-29; Total offering amount $140,949,151.
- 2018-09-05: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-08-23; Total offering amount $150,000,000.
- 2013-05-15: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-05-14; Total offering amount $4,500,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2020-06-12 | Rule 506(b) | Equity | 2020-05-29 | $41,905,000 | $41,905,000 | $0 | 38 |
|---|
| 2020-05-14 | Rule 506(b) | Equity | 2020-04-29 | $140,949,151 | $140,949,151 | $0 | 57 |
|---|
| 2018-09-05 | Rule 506(b) | Equity | 2018-08-23 | $150,000,000 | $150,000,000 | $0 | 52 |
|---|
| 2013-05-15 | Rule 506 | Equity | 2013-05-14 | $4,500,000 | $4,500,000 | $0 | 1 |
|---|
| 2013-03-21 | Rule 506 | Equity | 2013-03-07 | $59,999,448 | $59,999,448 | $0 | 32 |
|---|
| 2012-06-13 | Rule 506 | Equity | 2012-05-29 | $40,000,000 | $22,950,840 | $17,049,160 | 27 |
|---|
| 2009-12-22 | Rule 506 | Equity | 2009-12-22 | $50,300,000 | $25,150,064 | $25,149,936 | 21 |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|